Medicare Enrolled
Dr. Anish Meerasahib, M.D.
Hematology & Oncology · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meerasahib from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meerasahib?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meerasahib
Dr. Anish Meerasahib is a hematology & oncology specialist in Webster, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Meerasahib performed 93,974 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Meerasahib received a total of $5,819 from 43 pharmaceutical and/or device companies across 146 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meerasahib is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 9% volume in TX
$5,819 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗93,974
Medicare services
Top 9% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
31,110 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
16,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 9,700 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,125 | $2 | $20 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,000 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,710 | $0 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,855 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $19 | $67 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,905 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 945 | $3 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
900 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
855 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
777 | $10 | $64 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
621 | $2 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
596 | $98 | $368 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
441 | $23 | $157 |
| Injection, granisetron hydrochloride, 100 mcg | 325 | $0 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
261 | $105 | $707 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
228 | $2 | $300 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
207 | $12 | $108 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
150 | $22 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
133 | $52 | $344 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
133 | $61 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
132 | $11 | $96 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
125 | $51 | $313 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
122 | $7 | $431 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
97 | $6 | $31 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 91 | $91 | $657 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
90 | $1,185 | $4,802 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
89 | $1 | $7 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
64 | $35 | $143 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
63 | $16 | $94 |
| New patient office visit, complex (60-74 min) | 63 | $174 | $709 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
60 | $134 | $500 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
54 | $45 | $289 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
51 | $4 | $23 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
51 | $93 | $357 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
47 | $52 | $821 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $60 | $247 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
44 | $59 | $211 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $23 | $145 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
40 | $181 | $1,067 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
38 | $1 | $8 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
33 | $4 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $139 | $694 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $105 | $565 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
21 | $2 | $19 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
19 | $50 | $686 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
34.2% high complexity
61.7% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,819
Total received (2018-2024)
Avg $831/year across 7 years
Top 41% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
146
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,833
2023
$877
2022
$678
2021
$77
2020
$51
2019
$70
2018
$232
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$1,506
Novartis Pharmaceuticals Corporation
$1,352
Janssen Biotech, Inc.
$144
Celgene Corporation
$104
E.R. Squibb & Sons, L.L.C.
$103
PFIZER INC.
$98
Genentech USA, Inc.
$73
SpringWorks Therapeutics, Inc.
$72
Merck Sharp & Dohme LLC
$57
Incyte Corporation
$47
Astellas Pharma US Inc
$34
Lilly USA, LLC
$27
Daiichi Sankyo Inc.
$26
Janssen Pharmaceuticals, Inc
$26
PUMA BIOTECHNOLOGY, INC.
$25
ABBVIE INC.
$24
BeiGene USA, Inc.
$22
Gilead Sciences, Inc.
$21
Tempus AI, Inc
$21
GlaxoSmithKline, LLC.
$18
Genmab U.S., Inc.
$17
ARRAY BIOPHARMA INC
$15
Top 3 companies account for 78.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,573
Novartis Pharmaceuticals Corporation
$1,554
E.R. Squibb & Sons, L.L.C.
$334
PFIZER INC.
$210
Astellas Pharma US Inc
$204
Merck Sharp & Dohme LLC
$185
Celgene Corporation
$172
Janssen Biotech, Inc.
$157
Clovis Oncology, Inc.
$118
Seagen Inc.
$100
ARRAY BIOPHARMA INC
$86
Genentech USA, Inc.
$73
SpringWorks Therapeutics, Inc.
$72
Myriad Genetic Laboratories, Inc.
$65
TAIHO ONCOLOGY, INC.
$60
Daiichi Sankyo Inc.
$54
Rigel Pharmaceuticals, Inc.
$51
Stemline Therapeutics Inc.
$51
Lilly USA, LLC
$50
Incyte Corporation
$47
PUMA BIOTECHNOLOGY, INC.
$45
GlaxoSmithKline, LLC.
$41
Amgen Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$34
Gilead Sciences, Inc.
$33
GENZYME CORPORATION
$32
Pharming Healthcare, Inc.
$30
MorphoSys, US Inc.
$26
Janssen Pharmaceuticals, Inc
$26
PharmaEssentia USA Corporation
$25
Eisai Inc.
$25
ABBVIE INC.
$24
EISAI INC.
$24
Karyopharm Therapeutics Inc.
$23
Sobi, Inc
$22
BeiGene USA, Inc.
$22
Apellis Pharmaceuticals, Inc.
$22
Tempus AI, Inc
$21
Alexion Pharmaceuticals, Inc.
$20
Tactile Systems Technology Inc
$19
AVEO Pharmaceuticals, Inc.
$18
Genmab U.S., Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 59.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BESPONSA · BESREMI · BRAFTOVI · BRUKINSA · CALQUENCE · CARVYKTI · Columvi · DARZALEX · DOPTELET · ELAHERE · ENHERTU · ERLEADA · Enhertu · Epkinly · FOTIVDA · Fabhalta · Flexitouch Plus · GILOTRIF · IBRANCE · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · NERLYNX · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PROMACTA · Padcev · Polivy · Pomalyst · REBLOZYL · RUCONEST · Rubraca · SCEMBLIX · TABRECTA · TALVEY · TUKYSA · Tavalisse · ULTOMIRIS · VERZENIO · Venclexta · Vyloy · XALKORI · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
180
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meerasahib is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meerasahib experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Meerasahib performed 31,110 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Meerasahib receive payments from pharmaceutical companies?
Yes. Dr. Meerasahib received a total of $5,819 from 43 companies across 146 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meerasahib's costs compare to other hematology & oncology specialists in Webster?
Dr. Meerasahib's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meerasahib) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Webster
Browse hematology & oncology specialists in Webster ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology